Changes in high density lipoprotein subfraction lipids during neutral lipid transfer in healthy subjects and in patients with insulin-dependent diabetes mellitus

被引:5
作者
Ritter, MC [1 ]
Bagdade, JD [1 ]
机构
[1] RUSH MED COLL,RUSH PRESBYTERIAN ST LUKES MED CTR,ENDOCRINOL SECT,DEPT MED,CHICAGO,IL 60612
关键词
D O I
10.1007/BF02522403
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
While it is known that the transfer of cholesteryl ester (CE) from high density lipoprotein (HDL) to the apo B-containing lipoproteins is increased in patients with diabetes, the extent to which the various lipoprotein fractions engage in neutral lipid exchange and the magnitude to which triglyceride (TG) is translocated is not known. To examine in greater detail neutral lipid net mass transfer in diabetes, the HDL subfractions and the apo B-containing lipoproteins were separated, and the net mass transfer of CE and TG was compared to that of control subjects. in both groups, bidirectional transfer of CE from HDL, to very low density lipoprotein (VLDL) + low density lipoprotein (LDL) and of TG from VLDL + LDL to HDL(3), took place, but this process was significantly greater (P <.01) in insulin-dependent diabetes mellitus (IDDM). In contrast, CE and TC accumulated in HDL(2) to a similar degree in normal and IDDM subjects. In recombination experiments with each of the apo B-containing lipoproteins, IDDM VLDL had a greater capacity to facilitate the exchange of core lipids from both IDDM and control HDL(3): on the other hand, LDL from IDDM and control subjects both donated TG and CE to HDL(2) and affected little change in HDL(3). These findings indicate that all the major plasma fractions normally participate in the trafficking of CE and TG among the lipoproteins during neutral lipid transfer and show that the principal perturbation in cholesteryl ester transfer in IDDM involves altered interaction between VLDL and the HDL(3) subfraction.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 23 条
  • [11] MORTON RE, 1988, J BIOL CHEM, V263, P12235
  • [12] QUIG DW, 1990, ANNU REV NUTR, V10, P169, DOI 10.1146/annurev.nu.10.070190.001125
  • [13] PLASMA-LIPID TRANSFER PROTEIN AS A DETERMINANT OF THE ATHEROGENICITY OF MONKEY PLASMA-LIPOPROTEINS
    QUINET, E
    TALL, A
    RAMAKRISHNAN, R
    RUDEL, L
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (05) : 1559 - 1566
  • [14] PATHO-PHYSIOLOGY OF REVERSE CHOLESTEROL TRANSPORT - INSIGHTS FROM INHERITED DISORDERS OF LIPOPROTEIN METABOLISM
    REICHL, D
    MILLER, NE
    [J]. ARTERIOSCLEROSIS, 1989, 9 (06): : 785 - 797
  • [15] CONTRIBUTION OF GLYCEMIC CONTROL, ENDOGENOUS LIPOPROTEINS AND CHOLESTERYL ESTER TRANSFER PROTEIN TO ACCELERATED CHOLESTERYL ESTER TRANSFER IN IDDM
    RITTER, MC
    BAGDADE, JD
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (09) : 607 - 614
  • [16] RYE KA, 1992, STRUCTURE FUNCTION A, P401
  • [17] SWENSON TL, 1992, CURR OPIN LIPIDOL, V3, P67
  • [18] ACCELERATED TRANSFER OF CHOLESTERYL ESTERS IN DYSLIPIDEMIC PLASMA - ROLE OF CHOLESTERYL ESTER TRANSFER PROTEIN
    TALL, A
    GRANOT, E
    BROCIA, R
    TABAS, I
    HESLER, C
    WILLIAMS, K
    DENKE, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (04) : 1217 - 1225
  • [19] TALL AR, 1986, J LIPID RES, V27, P361
  • [20] TALL AR, 1993, J LIPID RES, V34, P1255